Fifth Third Bancorp reduced its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.4% in the fourth quarter, ...

Exchange Traded Concepts LLC lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 37.5% during the 4th ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...

Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

E-Mini Nasdaq 100 21740.50 115.75 0.54% ...

LG H&H Co. Ltd. 3.19% ₩4.63T LG H&H Co. Ltd. Pfd. Series 1 2.69% ₩4.63T ...

2-Year U.S. Treasury Note Continuous Contract $102.840-0.055-0.05% 5-Year U.S. Treasury Note Continuous Contract $106.477-0.141-0.13% 10-Year U.S. Treasury Note Continuous Contract $109.031-0.203 ...

Intel will report its Q4 earnings after the bell Thursday. Donald Trump's pick for commerce secretary underlined that big and broad tariffs are top of mind both for him and the president during his ...